secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2026-08-05T20:15:40+00:00
Accession:  0001193125-26-335157
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences stockholders approve increase in authorized shares to 500M and amendment to 2021 equity plan
--------------------------------------------------------------------------------

- Authorized common shares increased from 150M to 500M; approved with 62.99M votes for, 26.50M against.
- Amendment No. 1 to 2021 Stock Option and Incentive Plan approved with 46.37M for, 27.37M against, 15.75M broker non-votes.
- Special Meeting held August 5, 2026; quorum of 89.49M shares represented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312526335157/0001193125-26-335157-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312526335157/aura-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-335157

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer